---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 99-103, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Source Type: research
Membrane therapeutic plasma exchange with and without heparin anticoagulation
ConclusionsOur findings indicate that TPE procedures can be conducted safely with UH and, when necessary, without anticoagulation. The use of LMWH was associated with more complications when compared with use of UH and to TPE done without anticoagulation. Further studies are necessary to study its use during TPE procedures. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Bruna Brunetta Gavrani ć, Nikolina Bašić‐Jukić, Vedran Premužić, Petar Kes Tags: RESEARCH ARTICLE Source Type: research
Plasma failing visual inspection
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Autumn Allison, Marissa Delapaz, Claire Meena ‐Leist, Gina Drobena Tags: APHERESIS ILLUSTRATED Source Type: research
Performance and safety of femoral central venous catheters in pediatric autologous peripheral blood stem cell collection
ConclusionFemoral CVC are safe and effective for A‐HPCC in young pediatric patients. Femoral CVC performance was maintained over several days with few flow‐related alarms when compared to thoracic CVCs. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Laura Cooling, Sandra Hoffmann, Dawn Webb, Chisa Yamada, Robertson Davenport, Sung Won Choi Tags: RESEARCH ARTICLE Source Type: research
Therapeutic plasma exchange in children: one center's experience
ConclusionTPE is a safe apheresis method in children, even when performed as a long‐term therapy. Efficacy is high under selected conditions. A highly skilled and experienced staff is mandatory to ensure patient safety and efficacy. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Gerard Cortina, Violeta Ojinaga, Thomas Giner, Magdalena Riedl, Siegfried Waldegger, Alejandra Rosales, Raphaela Trojer, Johannes Hofer Tags: RESEARCH ARTICLE Source Type: research
Apheresis education in pathology residency
ConclusionsThe pathology department performed apheresis procedures in two‐thirds of pathology residency programs surveyed. AP/CP residents were more likely to be required to train in apheresis medicine if the pathology department performed these procedures at their institution. Apheresis medicine practitioners should review the Milestones for Apheresis education with their residency program director to optimize learning and clinical skills development. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Alexis R. Peedin, Yara A. Park, Jay S. Raval Tags: RESEARCH ARTICLE Source Type: research
A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy
ConclusionThe results of this pilot study suggest that IA is at least equally effective and safe compared to PE in CIDP patients. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Ina Lieker, Torsten Slowinski, Lutz Harms, Katrin Hahn, Juliane Klehmet Tags: RESEARCH ARTICLE Source Type: research
Pegylated granulocyte ‐colony stimulating factor versus non‐pegylated granulocyte‐colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta‐analysis
Abstract
Granulocyte‐colony stimulating factor (G‐CSF) mobilizes and increases the amount of hematopoietic stem cells in peripheral blood, enabling its harvest by few apheresis procedures. The pegylated G‐CSF has longer half‐life and is given once only, which is more comfortable for patients, whereas the non‐pegylated requires multiple daily injection because of its short half‐life. We summarized results of randomized trials comparing the efficacy and safety of pegylated and non‐pegylated G‐CSF for peripheral blood stem cell mobilization. We searched the Cochrane CENTRAL, MEDLINE, EMBASE, and two conference...
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Jew W. Kuan, Anselm T. Su, Chooi F. Leong Tags: RESEARCH ARTICLE Source Type: research
Clotting during autologous hematopoietic progenitor cells collection
Abstract
Autologous hematopoietic progenitor cell (HPC) transplant through peripheral blood mobilization and leukapheresis is a standard treatment for many patients with hematopoietic malignancies. Although leukapheresis is usually completed with no complications, we present a case in which the hematopoietic progenitor cells clotted during collection. The patient had no history of hypercoagulopathy. It was identified that the anticoagulant infusion line was partially constricted by a blood warmer clamp. The machine did not alarm. Most of the multiple Food and Drug Administration reports of clotting occurring during apheres...
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Authors: Amit Gokhale, NurJehan Quraishy, Viva Veemara, Heather Howdyshell, Lynn Murray, Jennifer Royer, Linda Salmi, Kristin Ricci, Hien Liu Tags: APHERESIS ILLUSTRATED Source Type: research
Impact of plerixafor (mozobil) on hospital efficiency: A single center experience
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 5-13, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - April 28, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 5-13, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - April 28, 2017 Category: Hematology Source Type: research
Impact of plerixafor (mozobil) on hospital efficiency: a single center experience
Abstract
Plerixafor (Mozobil) in combination with granulocyte colony‐stimulating factor (G‐CSF) has shown to increase mobilization of peripheral blood stem cells (PBSC) as compared to G‐CSF alone in patients undergoing autologous stem cell transplantation (ASCT). However, up to 25% of patients treated with G‐CSF alone still fail mobilization. Adding plerixafor to poor mobilizers allows to rescue these patients from mobilization failure and to reduce the number of apheresis sessions. The goal of this retrospective study was to capture the impact of plerixafor on treatment outcome and on apheresis department efficien...
Source: Journal of Clinical Apheresis - April 28, 2017 Category: Hematology Authors: Nabih Azar, Maya Ouzegdouh, Sylvain Choquet, V éronique Leblond Tags: RESEARCH ARTICLE Source Type: research
Special Issue Abstracts From the American Society for Apheresis 38th Annual Meeting May 3 ‐6, 2017 Fort Lauderdale, Florida
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - April 15, 2017 Category: Hematology Tags: Abstracts Source Type: research
Issue Information
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - April 15, 2017 Category: Hematology Tags: Issue Information Source Type: research
Cover Image
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - April 15, 2017 Category: Hematology Tags: Issue Information Source Type: research
